Open access · CC-BY
via OpenAlex
Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Shuangshuang Zhao, Yan Guo, Xunzhe Yin
Frontiers in Bioscience-Landmark · 2024 · ▲ 23 citations
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) has a global prevalence of 25% and is a leading cause of cirrhosis and hepatocellular carcinoma. The prevalence of MASLD has been increasing, mirroring the global increase in diabetes and metabolic syndrome. MASLD is a chronic and progressive condition characterized by inflammation, oxidative stress, insulin resistance, and disruptions in lipid metabolism. Programmed cell death (PCD) plays a pivotal role in determining the pathological aspects of MASLD, including liver inflammation, fibrosis, and even the potential for malignant transformation. PCD is a dominant process that is fundamental for eukaryotic growth and serves as a regulatory factor in MASLD. PCD encompasses various pathways, including autophagy(definition), ferroptosis, apoptosis, and pyroptosis. These PCD pathways can be activated at different stages of MASLD. The key effector molecules involved in these processes are central focal points in the development of therapeutic interventions for MASLD. Here, we comprehensively review the idea that targeted the modulation of the PCD pathway may be an effective approach for the prevention and/or treatment of MASLD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.31083/j.fbl2901030
- Canonical
- link ↗
- Fetched
- 2026-07-13 MST
Cite this
APA
Zhao, S., Guo, Y., & Yin, X. (2024). Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. <em>Frontiers in Bioscience-Landmark</em>. https://doi.org/10.31083/j.fbl2901030
Vancouver
Zhao S, Guo Y, Yin X. Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2901030.
BibTeX
@article{shuangshuang2024Autoph,
title = {Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease},
author = {Shuangshuang Zhao and Yan Guo and Xunzhe Yin},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2901030},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Obesity & Metabolic Syndrome 2023
Open access · CC-BY
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Cell Communication and Signaling 2025
Open access · CC-BY
Taming fatty liver: can taurine combat metabolic dysfunction in MASLD?
Basic & clinical pharmacology & toxicology 2026
Open access · OA
The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective.
Biomedicines 2026
Open access · CC-BY
RBP4 in Ageing
Hepatology communications 2026
Open access · OA
Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
Frontiers in sports and active living 2026
Open access · OA